第一单位：
Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Parana, Curitiba, PR, Brazil.
作者：
Ingrid Fatima,Zattoni [1]
;
Thales,Kronenberger [2]
;
Diogo Henrique,Kita [3]
;
Lais Danciguer,Guanaes [4]
;
Matheus Murmel,Guimarães [4]
;
Larissa,de Oliveira Prado [5]
;
Melanie,Ziasch [5]
;
Luis C,Vesga [6]
;
Fabiane,Gomes de Moraes Rego [5]
;
Geraldo,Picheth [5]
;
Marcos Brown,Gonçalves [7]
;
Miguel D,Noseda [8]
;
Diogo R B,Ducatti [8]
;
Antti,Poso [2]
;
Robert W,Robey [9]
;
Suresh V,Ambudkar [9]
;
Vivian Rotuno,Moure [10]
;
Alan Guilherme,Gonçalves [11]
;
Glaucio,Valdameri [12]
作者单位：
Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Parana, Curitiba, PR, Brazil.
[1]
School of Pharmacy, University of Eastern Finland, Faculty of Health Sciences, Kuopio, 70211, Finland; Department of Medical Oncology and Pneumology, Internal Medicine VIII, University Hospital of Tübingen, Otfried-Müller-Strasse 14, 72076, Tübingen, Germany.
[2]
Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Parana, Curitiba, PR, Brazil; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[3]
Department of Pharmacy, Federal University of Parana, Curitiba, PR, Brazil.
[4]
Department of Clinical Analysis, Federal University of Parana, Curitiba, PR, Brazil.
[5]
School of Pharmacy, University of Eastern Finland, Faculty of Health Sciences, Kuopio, 70211, Finland; Research Group in Biochemistry and Microbiology (GIBIM), School of Chemistry, Industrial University of Santander, A.A. 678, Bucaramanga, Colombia; Research Group on Organic Compounds of Medicinal Interest (CODEIM), Technological Park of Guatiguara, Industrial University of Santander, A. A. 678, Piedecuesta, Colombia.
[6]
Department of Physics, Federal Technological University of Paraná, 80230-901 Curitiba, Parana, Brazil.
[7]
Department of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Paraná, Brazil.
[8]
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[9]
Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Parana, Curitiba, PR, Brazil; Department of Clinical Analysis, Federal University of Parana, Curitiba, PR, Brazil.
[10]
Department of Pharmacy, Federal University of Parana, Curitiba, PR, Brazil. Electronic address: alan.goncalves@ufpr.br.
[11]
Pharmaceutical Sciences Graduate Program, Laboratory of Cancer Drug Resistance, Federal University of Parana, Curitiba, PR, Brazil; Department of Clinical Analysis, Federal University of Parana, Curitiba, PR, Brazil. Electronic address: gvaldameri@ufpr.br.
[12]
DOI
10.1016/j.cbi.2021.109718
PMID
34717915
发布时间
2025-05-30
换一批
